Quality Improvement Study Shifts HPV Vaccine Initiation to Earlier Age
Quality Improvement Study Shifts HPV Vaccine Initiation to Earlier Age https://pediatricsnationwide.org/wp-content/themes/corpus/images/empty/thumbnail.jpg 150 150 Aimee Swartz, MPH https://secure.gravatar.com/avatar/8bdd9e6ef7054d4583716cf52e8e366a?s=96&d=mm&r=gA QI project shows that it is feasible, and possibly beneficial, to routinely administer HPV vaccine at age 9. It is feasible, and possibly beneficial, to routinely administer the human papillomavirus (HPV) vaccine beginning at age 9 — two to three years earlier than currently recommended — according to findings from a recent study conducted…